Chung-Ang University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1918)

Organization Overview

First Clinical Trial
2009
NCT00823550
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Choung Ang University | Choung Ang University Hospital | Chung-Ang University | ChungAng University | Chungang University College of Medicine & Chungang University Hospital | Chung-Ang University Hospital | Chung-Ang University Hospital, Chung-Ang University College of Medicine | Chung-Ang University Hosptial, Chung-Ang University College of Medicine | Chung Ang University Hostpital | Chung-Ang University Medical Center | Chung-Ang university Yongsan Hospital | Chung-Ang University Yongsan Hospital | Chung-Ang University Yong-San Hospital | Department of Dermatology, Chungang University Hospital | Dept of Neurology, Chung-Ang University Hospital | Yong-Hee Park

Active Ingredients

Drugs in Phase 4 Trials (32)

5,7-dihydroxy-3',4',6-trimethoxyflavone (1 trial)

acetylsalicylic acid (aspirin) (2 trials)

cefmetazole (zefazone) (1 trial)

cyproviron (1 trial)

desflurane (suprane) (2 trials)

entecavir (baraclude) (1 trial)

epinephrine (levophed) (1 trial)

ezetimibe (zetia) (1 trial)

fentanyl (Innovar) (1 trial)

gabapentin (neurontin) (1 trial)

hifenac (1 trial)

ketorolac (acuvail) (1 trial)

lamivudine (epivir) (1 trial)

lidocaine (xylocaine) (5 trials)

misoprostol (cytotec) (1 trial)

morphine (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

nabumetone (relafen) (1 trial)

oxycodone (oxycontin) (1 trial)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

rimabotulinumtoxinB (Myobloc) (3 trials)

risedronate (actonel) (2 trials)

rivastigmine (exelon) (1 trial)

ropivacaine (naropin) (2 trials)

rosuvastatin (crestor) (1 trial)

sevoflurane (ultane) (1 trial)

sitagliptin (januvia) (1 trial)

sodium chloride (7 trials)

tenofovir alafenamide (genvoya) (1 trial)

tolvaptan (samsca) (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 3 Trials (26)

131i-lipiodol (Lipiodol) (1 trial)

agsct101 (1 trial)

amlodipine (norvasc) (1 trial)

amoxicillin (1 trial)

bismuth (1 trial)

capecitabine (xeloda) (1 trial)

carvedilol (coreg) (1 trial)

celecoxib (celebrex) (1 trial)

clarithromycin (biaxin) (2 trials)

donepezil (aricept) (1 trial)

gimeracil (2 trials)

hydrochlorothiazide (esidrix) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

irinotecan (Camptosar) (1 trial)

lansoprazole (prevacid) (1 trial)

levodropropizine (1 trial)

methylprednisolone (medrol) (1 trial)

metronidazole (flagyl) (2 trials)

olmesartan (benicar) (1 trial)

oteracil (2 trials)

rebamipide (2 trials)

recoflavone (1 trial)

tegafur (2 trials)

tegoprazan (1 trial)

tetracycline (tetrex) (1 trial)

theobromine (1 trial)

Drugs in Phase 2 Trials (25)

allogeneic adipose derived mesenchymal stem cell (1 trial)

belotecan (1 trial)

cisplatin (platinol) (2 trials)

cortisone acetate (cortone) (1 trial)

dwj211 (1 trial)

erlotinib (tarceva) (1 trial)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (2 trials)

idarubicin (idamycin) (1 trial)

lapatinib (tykerb) (1 trial)

leucovorin (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

oxaliplatin (eloxatin) (2 trials)

pac-14028 (4 trials)

pimecrolimus (elidel) (1 trial)

prednisone (meticorten) (1 trial)

s-1 (1 trial)

sirolimus (rapamune) (1 trial)

sorafenib (nexavar) (1 trial)

tacrolimus (prograf) (1 trial)

thiamine (1 trial)

topotecan (hycamtin) (1 trial)

tremelimumab (Imjudo) (1 trial)

vinorelbine (navelbine) (1 trial)

vitamin c (1 trial)

Drugs in Phase 1 Trials (1)

abobotulinumtoxinA (Dysport) (1 trial)

Drugs in Other Trials (6)

lactobacillus rhamnosus (1 trial)

melilotus officinalis (1 trial)

motilitone (1 trial)

olanzapine (zyprexa) (1 trial)

palonosetron (aloxi) (1 trial)

pantoprazole (protonix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Alzheimer Disease (Phase 3)

Ascites (Phase 4)

Biliary Tract Neoplasms (Phase 2)

Blepharospasm (Phase 4)

Breast Neoplasms (Phase 3)

Bronchitis (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Coronary Artery Disease (Phase 4)

Crohn Disease (Phase 4)

Delirium (Phase 4)

Dementia (Phase 4)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Dermatitis, Seborrheic (Phase 2)

Diabetes Mellitus, Type 2 (Phase 4)

Eczema (Phase 2)

Emergence Delirium (Phase 4)

Essential Hypertension (Phase 3)

Femoral Neck Fractures (Phase 4)

Gastritis (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hiccup (Phase 3)

Hypertension (Phase 3)

Hypertrophy (Phase 2)

Hyponatremia (Phase 4)

Ischemia (Phase 4)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Liver Diseases (Phase 4)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Neuralgia (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Osteoporosis (Phase 4)

Pain, Postoperative (Phase 4)

Pancreatic Neoplasms (Phase 2)

Psychomotor Agitation (Phase 4)

Rosacea (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Spinal Stenosis (Phase 4)

Stomach Neoplasms (Phase 3)

Stroke (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 63
  • # of Trial APIs: 90